Cargando…
Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave
The novel coronavirus disease 2019 (COVID-19) pandemic has been an overwhelming challenge for worldwide health systems. Since the beginning of year 2020, COVID-19 has represented a potential harm for cancer patients and has often hindered oncology care. The Collegio Italiano dei Primari Oncologi Med...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904514/ https://www.ncbi.nlm.nih.gov/pubmed/33743478 http://dx.doi.org/10.1016/j.ejca.2021.01.040 |
_version_ | 1783654947056779264 |
---|---|
author | Indini, Alice Pinotti, Graziella Artioli, Fabrizio Aschele, Carlo Bernardi, Daniele Butera, Alfredo Defraia, Efisio Fasola, Gianpiero Gamucci, Teresa Giordano, Monica Iaria, Antonino Leo, Silvana Ribecco, Angela S. Rossetti, Riccardo Savastano, Clementina Schena, Marina Silva, Rosa R. Grossi, Francesco Blasi, Livio |
author_facet | Indini, Alice Pinotti, Graziella Artioli, Fabrizio Aschele, Carlo Bernardi, Daniele Butera, Alfredo Defraia, Efisio Fasola, Gianpiero Gamucci, Teresa Giordano, Monica Iaria, Antonino Leo, Silvana Ribecco, Angela S. Rossetti, Riccardo Savastano, Clementina Schena, Marina Silva, Rosa R. Grossi, Francesco Blasi, Livio |
author_sort | Indini, Alice |
collection | PubMed |
description | The novel coronavirus disease 2019 (COVID-19) pandemic has been an overwhelming challenge for worldwide health systems. Since the beginning of year 2020, COVID-19 has represented a potential harm for cancer patients and has often hindered oncology care. The Collegio Italiano dei Primari Oncologi Medici (CIPOMO) is an Italian association of head physicians in oncology departments, which promotes working and research activities in oncology on a national basis. During the second wave of COVID-19 pandemic, the CIPOMO promoted a national survey aiming to evaluate the impact of COVID-19 on oncologists' clinical activity and what changes have been made compared with the Italian situation during the first wave of the pandemic. Overall, 138 heads of medical oncology departments participated in this survey: 75 (54%) from the North, 24 (17%) from the Centre and 39 (28%) from the South of Italy and islands. This survey provides an overview of Italian oncologists facing the second wave of COVID-19 pandemic. The lesson learned during the first wave of COVID-19 pandemic has led to a better organisation of clinical activities, and regular testing among healthcare practitioners, with better chances to grant patients' protection. However, the lack of standardised informatic platforms results in serious challenges in replacing frontal visits, often making a concrete reduction of patients' hospital accesses unfeasible. Oncologists need to keep preserving the continuum of care of patients. Standardisation of safety measures, together with the implementation of informatic platforms, can significantly improve oncology pathways during this second wave of COVID-19 pandemic. |
format | Online Article Text |
id | pubmed-7904514 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79045142021-02-25 Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave Indini, Alice Pinotti, Graziella Artioli, Fabrizio Aschele, Carlo Bernardi, Daniele Butera, Alfredo Defraia, Efisio Fasola, Gianpiero Gamucci, Teresa Giordano, Monica Iaria, Antonino Leo, Silvana Ribecco, Angela S. Rossetti, Riccardo Savastano, Clementina Schena, Marina Silva, Rosa R. Grossi, Francesco Blasi, Livio Eur J Cancer Original Research The novel coronavirus disease 2019 (COVID-19) pandemic has been an overwhelming challenge for worldwide health systems. Since the beginning of year 2020, COVID-19 has represented a potential harm for cancer patients and has often hindered oncology care. The Collegio Italiano dei Primari Oncologi Medici (CIPOMO) is an Italian association of head physicians in oncology departments, which promotes working and research activities in oncology on a national basis. During the second wave of COVID-19 pandemic, the CIPOMO promoted a national survey aiming to evaluate the impact of COVID-19 on oncologists' clinical activity and what changes have been made compared with the Italian situation during the first wave of the pandemic. Overall, 138 heads of medical oncology departments participated in this survey: 75 (54%) from the North, 24 (17%) from the Centre and 39 (28%) from the South of Italy and islands. This survey provides an overview of Italian oncologists facing the second wave of COVID-19 pandemic. The lesson learned during the first wave of COVID-19 pandemic has led to a better organisation of clinical activities, and regular testing among healthcare practitioners, with better chances to grant patients' protection. However, the lack of standardised informatic platforms results in serious challenges in replacing frontal visits, often making a concrete reduction of patients' hospital accesses unfeasible. Oncologists need to keep preserving the continuum of care of patients. Standardisation of safety measures, together with the implementation of informatic platforms, can significantly improve oncology pathways during this second wave of COVID-19 pandemic. Elsevier Ltd. 2021-05 2021-02-25 /pmc/articles/PMC7904514/ /pubmed/33743478 http://dx.doi.org/10.1016/j.ejca.2021.01.040 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Research Indini, Alice Pinotti, Graziella Artioli, Fabrizio Aschele, Carlo Bernardi, Daniele Butera, Alfredo Defraia, Efisio Fasola, Gianpiero Gamucci, Teresa Giordano, Monica Iaria, Antonino Leo, Silvana Ribecco, Angela S. Rossetti, Riccardo Savastano, Clementina Schena, Marina Silva, Rosa R. Grossi, Francesco Blasi, Livio Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave |
title | Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave |
title_full | Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave |
title_fullStr | Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave |
title_full_unstemmed | Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave |
title_short | Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave |
title_sort | management of patients with cancer during the covid-19 pandemic: the italian perspective on the second wave |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904514/ https://www.ncbi.nlm.nih.gov/pubmed/33743478 http://dx.doi.org/10.1016/j.ejca.2021.01.040 |
work_keys_str_mv | AT indinialice managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT pinottigraziella managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT artiolifabrizio managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT aschelecarlo managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT bernardidaniele managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT buteraalfredo managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT defraiaefisio managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT fasolagianpiero managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT gamucciteresa managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT giordanomonica managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT iariaantonino managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT leosilvana managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT ribeccoangelas managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT rossettiriccardo managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT savastanoclementina managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT schenamarina managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT silvarosar managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT grossifrancesco managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave AT blasilivio managementofpatientswithcancerduringthecovid19pandemictheitalianperspectiveonthesecondwave |